切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - RET - MER - calcium uptake - Progesterone Receptors

10 件产品

每页
清除全部
  1. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: 口服生物可利用的双重MER/FLT3抑制剂
      ≥23.85 mg/mL
      ≥6.09 mg/mL
  2. Medroxyprogesterone
    B3471 Medroxyprogesterone
    中文名: 甲羟孕酮
    Target: Progesterone Receptors
    Summary: 强效孕酮受体激动剂
      ≥34.4 mg/mL
      insoluble in H2O
  3. Etonogestrel
    B3470 Etonogestrel
    中文名: 依托孕烯
    Target: Progesterone Receptors
    Summary: 甾体孕激素
      ≥15.05 mg/mL
      insoluble in H2O
  4. Medroxyprogesterone acetate
    B1510 Medroxyprogesterone acetate
    中文名: 醋酸甲羟孕酮
    Target: Progesterone Receptors
    Summary: 类固醇孕激素
      ≥9.48 mg/mL
      insoluble in H2O
  5. Mifepristone
    B1511 Mifepristone
     3 Citation
    中文名: 美服培酮
    Target: Progesterone Receptors|Glucocorticoid Receptors
    Summary: 孕激素受体拮抗剂
      ≥21.48 mg/mL
      insoluble in H2O
  6. Ranolazine
    A8510 Ranolazine
     1 Citation
    中文名: 雷诺嗪
    Target: calcium uptake
    Summary: 抗缺血
      ≥17.4 mg/mL
      insoluble in H2O
  7. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  8. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  9. AST 487
    A3194 AST 487
     1 Citation
    Target: RET
    Summary: RET激酶抑制剂
      ≥26.5 mg/mL
      insoluble in H2O
  10. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Aurora A/Flt3的选择性抑制剂
      ≥18.75 mg/mL
      insoluble in H2O

10 件产品

每页